<SEC-DOCUMENT>0001373604-25-000028.txt : 20250214
<SEC-HEADER>0001373604-25-000028.hdr.sgml : 20250214
<ACCEPTANCE-DATETIME>20250214100626
ACCESSION NUMBER:		0001373604-25-000028
CONFORMED SUBMISSION TYPE:	SCHEDULE 13G/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20250214
DATE AS OF CHANGE:		20250214

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PMV Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001699382
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				463218129
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-91714
		FILM NUMBER:		25624334

	BUSINESS ADDRESS:	
		STREET 1:		400 ALEXANDER PARK DRIVE
		STREET 2:		SUITE 301
		CITY:			PRINCETON
		STATE:			NJ
		ZIP:			08540
		BUSINESS PHONE:		(609) 642-6670

	MAIL ADDRESS:	
		STREET 1:		400 ALEXANDER PARK DRIVE
		STREET 2:		SUITE 301
		CITY:			PRINCETON
		STATE:			NJ
		ZIP:			08540

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BML Investment Partners, L.P.
		CENTRAL INDEX KEY:			0001373604
		ORGANIZATION NAME:           	
		IRS NUMBER:				383708345
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G/A

	BUSINESS ADDRESS:	
		STREET 1:		156 S. FIRST STREET
		CITY:			ZIONSVILLE
		STATE:			IN
		ZIP:			46077
		BUSINESS PHONE:		317-344-6689

	MAIL ADDRESS:	
		STREET 1:		156 S. FIRST STREET
		CITY:			ZIONSVILLE
		STATE:			IN
		ZIP:			46077
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13G/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:com="http://www.sec.gov/edgar/common">
<headerData>
<submissionType>SCHEDULE 13G/A</submissionType>
<previousAccessionNumber>0001373604-24-000110</previousAccessionNumber>
<filerInfo>
<filer>
<filerCredentials>
<cik>0001373604</cik>
<ccc>XXXXXXXX</ccc>
</filerCredentials>
</filer>
<liveTestFlag>LIVE</liveTestFlag>



</filerInfo>
</headerData>
<formData>
<coverPageHeader>
<amendmentNo>1</amendmentNo>
<securitiesClassTitle>Common Stock, $0.00001 par value per share</securitiesClassTitle>
<eventDateRequiresFilingThisStatement>12/31/2024</eventDateRequiresFilingThisStatement>
<issuerInfo>
<issuerCik>0001699382</issuerCik>
<issuerName>PMV Pharmaceuticals, Inc.</issuerName>
<issuerCusip>69353Y103</issuerCusip>
<issuerPrincipalExecutiveOfficeAddress>
<com:street1>400 Alexander Park Drive, Suite 301</com:street1>
<com:city>Princeton</com:city>
<com:stateOrCountry>NJ</com:stateOrCountry>
<com:zipCode>08540</com:zipCode>
</issuerPrincipalExecutiveOfficeAddress>
</issuerInfo>
<designateRulesPursuantThisScheduleFiled>
<designateRulePursuantThisScheduleFiled>Rule 13d-1(c)</designateRulePursuantThisScheduleFiled>
</designateRulesPursuantThisScheduleFiled>
</coverPageHeader>
<coverPageHeaderReportingPersonDetails>

<reportingPersonName>BML Investment Partners, L.P.</reportingPersonName>
<memberGroup>b</memberGroup>
<citizenshipOrOrganization>DE</citizenshipOrOrganization>
<reportingPersonBeneficiallyOwnedNumberOfShares>
<soleVotingPower>0</soleVotingPower>
<sharedVotingPower>3269907</sharedVotingPower>
<soleDispositivePower>0</soleDispositivePower>
<sharedDispositivePower>3269907</sharedDispositivePower>
</reportingPersonBeneficiallyOwnedNumberOfShares>
<reportingPersonBeneficiallyOwnedAggregateNumberOfShares>3269907</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
<aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
<classPercent>6.3</classPercent>
<typeOfReportingPerson>PN</typeOfReportingPerson>
</coverPageHeaderReportingPersonDetails>
<items>
<item1>
<issuerName>PMV Pharmaceuticals, Inc.</issuerName>
<issuerPrincipalExecutiveOfficeAddress>400 Alexander Park Drive, Suite 301, Princeton, New Jersey, 08540</issuerPrincipalExecutiveOfficeAddress>
</item1>
<item2>
<filingPersonName>BML Investment Partners, L.P.</filingPersonName>
<principalBusinessOfficeOrResidenceAddress>65 E Cedar, Suite 2 Zionsville, IN 46077</principalBusinessOfficeOrResidenceAddress>
<citizenship>Delaware</citizenship>
</item2>
<item3>
<notApplicableFlag>Y</notApplicableFlag>
</item3>
<item4>
<amountBeneficiallyOwned>3,269,907</amountBeneficiallyOwned>
<classPercent>6.3</classPercent>
<numberOfSharesPersonHas>
<solePowerOrDirectToVote>0</solePowerOrDirectToVote>
<sharedPowerOrDirectToVote>3,269,907</sharedPowerOrDirectToVote>
<solePowerOrDirectToDispose>0</solePowerOrDirectToDispose>
<sharedPowerOrDirectToDispose>3,269,907</sharedPowerOrDirectToDispose>
</numberOfSharesPersonHas>
</item4>
<item5>
<notApplicableFlag>Y</notApplicableFlag>
</item5>
<item6>
<notApplicableFlag>Y</notApplicableFlag>
</item6>
<item7>
<notApplicableFlag>Y</notApplicableFlag>
</item7>
<item8>
<notApplicableFlag>Y</notApplicableFlag>
</item8>
<item9>
<notApplicableFlag>Y</notApplicableFlag>
</item9>
<item10>
<notApplicableFlag>N</notApplicableFlag>
<certifications>By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.</certifications>
</item10>
</items>
<signatureInformation>
<reportingPersonName>BML Investment Partners, L.P.</reportingPersonName>
<signatureDetails>
<signature>Braden M Leonard</signature>
<title>BML Capital Management, LLC its General Partner By: Braden M Leonard, its Managing Member</title>
<date>02/14/2025</date>
</signatureDetails>
</signatureInformation>
<signatureComments>BML Investment Partners, L.P. is a Delaware limited partnership whose sole general partner is BML Capital Management, LLC. The managing member of BML Capital Management, LLC is Braden M. Leonard. As a result, Braden M. Leonard is deemed to be the indirect owner of the shares held directly by BML Investment Partners, L.P. Despite such shared beneficial ownership, the reporting persons disclaim that they constitute a statutory group within the meaning of Rule 13d-5(b)(1) of the Exchange Act.</signatureComments>
</formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
